Patents Assigned to Medra, Inc.
  • Publication number: 20030086915
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: May 8, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030064022
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: April 3, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030064059
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: April 3, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030064057
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: April 3, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030059408
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: March 27, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030059415
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: March 27, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030053992
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: March 20, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030053997
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: March 20, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030053996
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: March 20, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030049206
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: March 13, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030049238
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 28, 2002
    Publication date: March 13, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030049233
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: March 13, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller
  • Publication number: 20030039642
    Abstract: The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
    Type: Application
    Filed: October 25, 2002
    Publication date: February 27, 2003
    Applicant: Medra, Inc.
    Inventors: William C. Rader, Albert Scheller